Meeting
2023 ASCO Annual Meeting
SEER analysis of 9-year breast cancer specific mortality (BCSM) in patients (pts) with invasive lobular breast cancer (ILC) assessed by the 21-gene Breast Recurrence Score assay.
Authors
Charles E. Geyer Jr.
UPMC HIllman Cancer Center, Pittsburgh, PA
Charles E. Geyer Jr., John Bennett , Gong Tang , Jennifer M. Racz , Christy Ann Russell , Jung S. Byun , Julia Foldi , Frederick L. Baehner , Valentina I. Petkov
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 554)
DOI
10.1200/JCO.2023.41.16_suppl.554
Abstract #
554
Poster Bd #
384
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Associations between body mass index with cancer recurrence and all-cause mortality among survivors of breast cancer.
First Author: Po-Hua Chen
Poster
2023 ASCO Annual Meeting
Treatment outcomes in patients with discordant recurrence score and RSClin risk predictions.
First Author: Augustin Vannier
Poster
2021 ASCO Annual Meeting
Validation of the RSClin risk calculator using the National Cancer Database (NCDB).
First Author: Frederick Howard
Poster
2020 ASCO Virtual Scientific Program
Integration of the stem cell biology-based genomic tool, StemPrintER, with clinicopathological parameters for the prediction of distant recurrence in ER+/HER2- breast cancer (BC) patients.
First Author: Salvatore Pece